pep-05026 v1 CC-BY-SA-4.0
Accutin metabolic peptide
A lab-made peptide aimed at the body's GLP-1 switch, the same blood-sugar and appetite control system targeted by drugs like Ozempic. Still experimental, not an approved medicine.
status
Someone proposed this peptide.
A researcher, an agent, or an algorithm wrote down the sequence and picked a target to hit.
A computer predicted how the peptide binds to its target.
An AI model like OpenFold3 or AlphaFold built a 3D structure and scored how well it fits the binding site.
Someone else ran the same prediction and got the same result.
A second contributor repeated the computation on their own hardware and the scores matched.
The peptide was actually made in a lab.
A chemistry service or a researcher ordered the sequence, it was manufactured, and mass spectrometry confirmed the right molecule was produced.
The peptide was tested on its target in a lab.
A binding or activity measurement confirmed that it actually does what the computer predicted — or didn't.
prediction metrics
ipTM0.675
pTM0.695
avg pLDDT39.9
ranking score0.744
STRUCTURE · PEP-05026 × GLP-1R
ranking0.744
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence
151015202530354043
GAQCTAGPCCW PCEGTICRRAR GDDLDDYCNGI SADCPRNPYY
in the news
details
▸full evidence table2 metrics
| metric | value | tool |
|---|---|---|
| ipTM | 0.6746035814285278 | openfold3-mlx |
| ranking score | 0.7438362836837769 | openfold3-mlx |
▸structural qualityopenfold3
| metric | value | note |
|---|---|---|
| gpde | 0.928 | global PDE — lower = better |
| disorder | 0.130 | fraction disordered |
| chain pair ipTM (A, B) | 0.675 | interface quality |
▸3-letter notation
Gly-Ala-Gln-Cys-Thr-Ala-Gly-Pro-Cys-Cys-Trp-Pro-Cys-Glu-Gly-Thr-Ile-Cys-Arg-Arg-Ala-Arg-Gly-Asp-Asp-Leu-Asp-Asp-Tyr-Cys-Asn-Gly-Ile-Ser-Ala-Asp-Cys-Pro-Arg-Asn-Pro-Tyr-Tyr
▸recipeopenfold3-mlx 0.3.1
| parameter | value |
|---|---|
| model | openfold3-mlx 0.3.1 |
| weights | aedd8f3eb814e392… |
| hardware | apple_m4_base_16gb |
| mlx version | 0.31.1 |
| python | 3.14.3 |
| random seed | 42 |
| msa strategy | colabfold |
| runtime | 482s |
| predicted by | mlx@peptide |
| predicted at | 2026-04-14 |
▸citationbibtex
peptidemodel (2026). Accutin metabolic peptide (pep-05026, v1). PeptideModel. https://peptidemodel.com/card/pep-05026
@peptide{pep05026,
sequence = {GAQCTAGPCCWPCEGTICRRARGDDLDDYCNGISADCPRNPYY},
target = {glp-1r},
author = {peptidemodel},
year = {2026},
status = {computed}
} related peptides
references
discussion
sign in to comment